Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa

Published:2021-12-22 Issue:3 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Hu Yanyan¹,Qing Yan¹,Chen Jiawei¹,Liu Congcong¹,Lu Jiayue¹,Wang Qi¹,Zhen Shufang²,Zhou Hongwei¹^ORCID,Huang Ling¹³,Zhang Rong¹

Affiliation:

1. Clinical Microbiology Laboratory, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang University, Hangzhou, China

2. Department of Clinical Laboratory, Jinhua People’s Hospital, Jinhua, China

3. Department of Clinical Laboratory Medicine, Maternal and Child Health Hospital of Linping District, Hangzhou, China

Abstract

Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes.

Funder

NSF | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.01344-21

Reference31 articles.

1. Pseudomonas aeruginosa – a phenomenon of bacterial resistance

2. Pseudomonasgenomes: diverse and adaptable

3. Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa

4. Physical stress and bacterial colonization

5. Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of antimicrobial selective pressure using the multicenter semiautomatic surveillance system Japan surveillance for infection prevention and healthcare epidemiology;Journal of Infection and Public Health;2024-08

2. In search of the best method to detect carriage of carbapenem-resistant Pseudomonas aeruginosa in humans: a systematic review;Annals of Clinical Microbiology and Antimicrobials;2024-06-10

3. Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosa;International Journal of Antimicrobial Agents;2024-05

4. Role of β-lactamases and efflux pumps in multidrug resistance inPseudomonas aeruginosaisolated from patients in the Intensive Care Unit in the northeast of Brazil;2024-04-24

5. A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-04-06